September 26, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Atara immunotherapy for mesothelioma promising

IN THIS ARTICLE

New data presented by Memorial Sloan Kettering at the American Society of Clinical Oncology in Chicago June 4 showed promising results for mesothelioma patients with solid tumors who were given a new immunotherapy from Atara Biotherapeutics. The CAR T therapy targeting mesothelin was delivered along with chemotherapy. The results ”reaffirm mesothelin as a promising target…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.